| REVIEW ARTICLE |
|
| Year : 2020 | Volume
: 36
| Issue : 3 | Page : 163-170 |
|
|
COVID-19 and its impact on genitourinary malignancies
C Danny Darlington1, Rohan J Mammen1, Kim J Mammen2
1 Department of Urology, Pondicherry Institute of Medical Sciences, Puducherry, India
2 Department of Urology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
Correspondence Address:
Dr. C Danny Darlington
Department of Urology, Pondicherry Institute of Medical Sciences, Puducherry
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/iju.IJU_167_20
|
|
|
The severe acute respiratory syndrome coronavirus 2 has emerged as an alarming disease since December 2019, claiming the lives of thousands across the world to date. This pandemic has burdened healthcare systems all over the world due to its heavy death toll. Researchers are actively working on effective treatment strategies, the scope of vaccination and the production of more medical equipment to tackle this crisis. However, it is important to note that the management of patients with malignancy also needs to be prioritized during such times. Some urological malignancies need early diagnosis and treatment while the diagnosis and treatment of several others can be safely delayed. Hence, we searched MEDLINE for evidence on the optimal management of urological cancers during the coronavirus disease (COVID-19) pandemic. Studies published from December 2019 to April 2020 were included in the review. Guidelines formulated by international and national urological societies were also included. This review aims to summarize the present evidence on effective triage and safe management of urological cancers amid COVID-19 pandemic to ensure efficient usage of healthcare resources during these unprecedented times.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
